Abstract FR536: Experimental Animal Models of Preeclampsia: Mechanisms, Strengths, and Translational Relevance
Hypertension · 2026-10 · 83 (Suppl_1)
DOI: 10.1161/hyp.83.suppl_1.fr536 ↗Kurz gefasst
Fachartikel in der Zeitschrift Hypertension, 2026-10. Verfasst von Vladimir Dokic und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Preeclampsia (PE) is a heterogeneous hypertensive disorder of pregnancy characterized by new-onset hypertension and end-organ dysfunction, affecting 5-10% of pregnancies globally. It is associated with significant maternal and fetal morbidity and mortality, and delivery remains the only definitive treatment. Understanding the underlying mechanisms is essential for the development of effective therapies.
Objectives
The goal of this study is to critically assess experimental animal models of PE within a mechanistic framework, with emphasis on their translational relevance, to identify gaps in knowledge, and inform future strategies for modeling and treating this complex disorder.
Methods
A systematic, artificial intelligence (AI)-assisted literature search and analysis was performed on January 23, 2026. The public website of the PubMed database was searched, using the query "Pre-Eclampsia"[MeSH] AND "Models, Animal"[MeSH] with exclusion of reviews, editorials, comments, and letters dating back to the year of 1968. A total of 642 publications were retrieved, and metadata including abstracts were compiled into a single dataset. The final annotated literature review consisted of 609 publications.
Results
The most frequently used species was rat (357 publications), followed by mice (229 publications). The animal model methods were grouped into 15 mechanistic categories, with the most common approaches targeting nitric oxide/endothelin-1 pathways (21.5%), placental ischemia including reduced uterine perfusion pressure (RUPP)-based models and abnormal placentation (20.5%), and spontaneous/superimposed preeclampsia and other genetic models (12.5%) as shown in Figure 1 . Summary: Current models reproduce distinct features of PE, including abnormal placentation, placental ischemia, angiogenic imbalance, endothelial dysfunction, immune activation, and metabolic dysregulation. Despite mechanistic insights, translational success has been limited. Human PE frequently occurs in the context of maternal comorbidities such as obesity, chronic hypertension, and metabolic syndrome. However, these factors are incompletely represented in experimental models and most models do not integrate multiple risk factors simultaneously. Future progress will depend on mechanism-driven model selections, development of models that better capture early placentation defects and disease heterogeneity, multi-hit approaches, including incorporation of maternal comorbidities, and integration of human-relevant experimental systems to improve clinical translation.
Zitieren
APA
Dokic, V., Garovic, V. D., Lin, M., Fan, J., & Reckelhoff, J. F. (2026). Abstract FR536: Experimental Animal Models of Preeclampsia: Mechanisms, Strengths, and Translational Relevance. Hypertension, 83(Suppl_1). https://doi.org/10.1161/hyp.83.suppl_1.fr536
Vancouver
Dokic V, Garovic VD, Lin M, Fan J, Reckelhoff JF. Abstract FR536: Experimental Animal Models of Preeclampsia: Mechanisms, Strengths, and Translational Relevance. Hypertension. 2026;83(Suppl_1). doi:10.1161/hyp.83.suppl_1.fr536
BibTeX
@article{Dokic2026,
author = {Dokic, Vladimir and Garovic, Vesna D and Lin, Michael and Fan, Jungwei and Reckelhoff, Jane F},
title = {Abstract FR536: Experimental Animal Models of Preeclampsia: Mechanisms, Strengths, and Translational Relevance},
journal = {Hypertension},
year = {2026},
volume = {83},
number = {Suppl_1},
doi = {10.1161/hyp.83.suppl_1.fr536}
}
EUVIMED